✦ LIBER ✦

GPIIb–IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary intervention

✍ Scribed by M. I. FURMAN; L. A. KRUEGER; M. D. LINDEN; M. L. FOX; S. P. BALL; M. R. BARNARD; A. L. FRELINGER III; A. D. MICHELSON

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effectiveness of the transradial approac

✍ Marco De Carlo; Gabriele Borelli; Roberto Gistri; Nicola Ciabatti; Alessandra Ma 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 2 views

Use of IIb/IIIa inhibitors in patients w

✍ Mardi Gomberg-Maitland; Jonathan L Halperin 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Prasugrel versus clopidogrel in acute co

✍ Deepak L. Bhatt 📂 Article 📅 2008 🏛 Current Science Inc. 🌐 English ⚖ 161 KB

IIb/IIIa inhibitors: Effects on acute ou

✍ Mark Horrigan 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 243 KB

Pharmacokinetics of intravenous/subcutan

✍ Muhammad Shakil Aslam; Steve Sundberg; M. Nagui Sabri; David Cooke; Jeffrey B. L 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 2 views

Impact of Bleeding on Outcomes in Patien

✍ D. Stub; N. Andrianopoulos; A. Brennan; P. Loane; R. Sharma; A. Ajani; G. New; A 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 108 KB